89 results
Page 3 of 5
8-K
EX-99.1
dsxv itue34waz
16 Jul 20
Results of Operations and Financial Condition
9:17am
8-K
EX-10.1
qt6u811b7im my1kg8a1
12 Jun 20
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-99.1
w2e271wh o5slgni
3 Jun 20
Regulation FD Disclosure
4:32pm
8-K
EX-10.1
99uzp
8 May 20
Entry into a Material Definitive Agreement
9:08am
D
l1hcck lhvmb
7 May 20
$395 in equity, sold $395, 1 investor
2:49pm
D
matcgk 9qr2ix5t5le9
7 May 20
$14.28M in equity / debt, sold $14.28M, 6 investors
2:43pm
8-K
EX-10.1
901ytk2vi7sb5xzvbj
1 May 20
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-99.1
5be6pw91ulu6k
13 Apr 20
Regulation FD Disclosure
11:50am
8-K
EX-99.1
h1lgksgb13niu03og w8
14 Feb 20
Regulation FD Disclosure
8:00am
424B3
oecotwynha3mxhtg
6 Aug 19
Prospectus supplement
4:46pm
S-4/A
g07yaeqir06l
23 Jul 19
Registration of securities issued in business combination transactions (amended)
2:34pm
S-4
qqqjl
14 Jun 19
Registration of securities issued in business combination transactions
5:22pm
S-4
EX-10.38
v93ruu6t93re
14 Jun 19
Registration of securities issued in business combination transactions
5:22pm
S-4
EX-10.47
v3guzzm3kos997
14 Jun 19
Registration of securities issued in business combination transactions
5:22pm
8-K
EX-10.1
cmuh3
14 Jun 19
Entry into a Material Definitive Agreement
8:32am
425
EX-10.1
nkbqwv7
14 Jun 19
Business combination disclosure
8:30am
8-K
EX-2.1
2zykipa8s07rwfd8l
8 Apr 19
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage
7:17am